Akso Health Group (AHG)

Akso Health Group Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	8.45	2.41	13.18	6	-	3.87
Other Revenue	-	-	-	-	-	3.04
Revenue	8.45	2.41	13.18	6	-	6.91
Revenue Growth (YoY)	281.19%	-81.68%	119.69%	-	-	87.12%
Cost of Revenue	8.18	2.29	11.91	5.39	-	-
Gross Profit	0.28	0.12	1.27	0.61	-	6.91
Selling, General & Admin	7.14	8.76	15.54	2.67	2.03	22.98
Operating Expenses	7.14	8.76	15.54	3.06	2.09	23.33
Operating Income	-6.86	-8.64	-14.27	-2.46	-2.09	-16.42
Interest Expense	-	-	-	-0.8	-2.15	-2.5
Currency Exchange Gain (Loss)	0.05	-0.59	1.14	-0.75	-	-
Other Non Operating Income (Expenses)	0.24	0.14	0.06	0	-0.05	1.25
EBT Excluding Unusual Items	-6.57	-9.09	-13.07	-4.01	-4.29	-17.67
Gain (Loss) on Sale of Investments	-	-	-	-	-	-29.19
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0.02
Pretax Income	-6.57	-9.09	-13.07	-4.01	-4.29	-46.87
Income Tax Expense	0.04	0.02	0.02	0.09	-	0.49
Earnings From Continuing Operations	-6.61	-9.12	-13.08	-4.1	-4.29	-47.36
Earnings From Discontinued Operations	-0.01	-0.4	11.84	-12.75	-30.53	-23.83
Net Income to Company	-6.61	-9.52	-1.25	-16.85	-34.83	-71.2
Minority Interest in Earnings	0.02	0.06	-0.11	-0	-	-
Net Income	-6.59	-9.46	-1.36	-16.85	-34.83	-71.2
Net Income to Common	-6.59	-9.46	-1.36	-16.85	-34.83	-71.2
Shares Outstanding (Basic)	152	47	23	20	16	16
Shares Outstanding (Diluted)	152	47	23	20	16	16
Shares Change (YoY)	565.82%	106.30%	15.07%	22.06%	0.17%	0.13%
EPS (Basic)	-0.04	-0.20	-0.06	-0.85	-2.14	-4.38
EPS (Diluted)	-0.05	-0.22	-0.08	-0.85	-2.15	-4.38
Free Cash Flow	-3.87	1.35	-3.25	-8.63	10.06	-58.48
Free Cash Flow Per Share	-0.03	0.03	-0.14	-0.43	0.62	-3.60
Gross Margin	3.26%	5.06%	9.63%	10.09%	-	100.00%
Operating Margin	-81.17%	-357.78%	-108.23%	-40.94%	-	-237.43%
Profit Margin	-77.92%	-391.77%	-10.32%	-280.85%	-	-1029.70%
Free Cash Flow Margin	-45.75%	55.97%	-24.68%	-143.81%	-	-845.75%
EBITDA	-	-	-14.25	-2.44	-2.07	-16.3
EBITDA Margin	-	-	-108.09%	-40.63%	-	-235.69%
D&A For EBITDA	-	-	0.02	0.02	0.02	0.12
EBIT	-6.86	-8.64	-14.27	-2.46	-2.09	-16.42
EBIT Margin	-81.17%	-	-108.23%	-40.94%	-	-237.43%
Revenue as Reported	8.45	2.41	13.18	6	-	6.91
Advertising Expenses	-	0.17	0.01	-	-	0.74

Updated Jul 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q